Harvard Bioscience (HBIO) Receivables (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Receivables of $14.6 million for Q1 2026, up 8.11% year-over-year from $13.5 million in Q1 2025, and down 9.17% quarter-over-quarter from $16.0 million in Q4 2025.
Harvard Bioscience (HBIO) Receivables (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Receivables for 17 consecutive years, with $14.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables rose 8.11% year-over-year to $14.6 million; the TTM figure through Mar 2026 stood at $14.6 million (up 8.11% YoY), while the FY2025 annual figure was $16.0 million, up 7.92% from the prior year.
- Receivables eased to $14.6 million in Q1 2026 per HBIO's latest filing, from $16.0 million in the prior quarter.
- Across five years, Receivables topped out at $20.3 million in Q1 2022 and bottomed at $11.9 million in Q2 2025.
- Historically, Receivables has averaged $15.2 million across 5 years, with a median of $15.0 million in 2022.
- Annual changes were most pronounced in 2022 — Receivables increased 18.74% — and 2024, when it slipped 26.13%.
- Harvard Bioscience's Receivables stood at $16.7 million in 2022, then slipped by 3.63% to $16.1 million in 2023, then dropped by 7.66% to $14.9 million in 2024, then rose by 7.92% to $16.0 million in 2025, then dropped by 9.17% to $14.6 million in 2026.
- Business Quant data shows HBIO's Receivables at $14.6 million in Q1 2026, $16.0 million in Q4 2025, and $12.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.67 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.36 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 2.08 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.08 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 3.66 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 712.00 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 1.43 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 809.20 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1.92 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 14.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.50 Mn |
| Mar 31, 2026 | 14.57 Mn |
| Dec 31, 2025 | 16.04 Mn |
| Sep 30, 2025 | 12.11 Mn |
| Jun 30, 2025 | 11.94 Mn |
| Mar 31, 2025 | 13.48 Mn |
| Dec 31, 2024 | 14.87 Mn |
| Sep 30, 2024 | 12.83 Mn |
| Jun 30, 2024 | 12.49 Mn |
| Mar 31, 2024 | 15.31 Mn |
| Dec 31, 2023 | 16.10 Mn |
| Sep 30, 2023 | 14.98 Mn |
| Jun 30, 2023 | 16.90 Mn |
| Mar 31, 2023 | 17.74 Mn |
| Dec 31, 2022 | 16.71 Mn |
| Sep 30, 2022 | 15.02 Mn |
| Jun 30, 2022 | 17.85 Mn |
| Mar 31, 2022 | 20.27 Mn |
| Dec 31, 2021 | 21.83 Mn |
| Sep 30, 2021 | 18.34 Mn |